Advertisement

Alterations in tRNA Metabolism as Markers of Neoplastic Transformation

  • Ronald W. Trewyn
  • Mark S. Elliott
  • Ronald Glaser
  • Michael R. Grever
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)

Abstract

Numerous changes in tRNA modification and catabolism are observed when cells undergo neoplastic transformation. The nature of certain of these changes is well established, while others require further characterization. Enzymes involved in the macromolecular modification of tRNA, the tRNA methyltransferases, exhibit idiosyncratic alterations during neoplastic transformation. These alterations include increases in enzyme specific activity as well as the appearance of different tRNA methyltransferases in the malignant tissue1,2. The increased tRNA methyltransferase activity and capacity observed in vitro for the enzymes isolated from transformed cells can also be correlated to increased methylation of specific tRNA iso accepting species, although not total tRNA, in vivo 3.

Keywords

Acute Myelogenous Leukemia Neoplastic Transformation Chinese Hamster Cell Line Methylated Acute Myelogenous Leukemia Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. J. Kerr and E. Borek, The tRNA methyltransferases, Adv. Enzymol. 36: 1 (1972).Google Scholar
  2. 2.
    S. J. Kerr, tRNA methyltransferases in normal and neoplastic tissues, in: “Isozymes: Developmental Biology,” Vol. III, pp. 855, Academic Press. New York (1975).Google Scholar
  3. 3.
    Y. Kuchino and E. Borek, Tumour-specific phenylalanine tRNA contains two supernumerary methylated bases, Nature 271: 126 (1978).CrossRefGoogle Scholar
  4. 4.
    E. Borek and S. J. Kerr, Atypical transfer RNA’s and their origin in neoplastic cells, Adv. Cancer Res. 15: 163 (1972).CrossRefGoogle Scholar
  5. 5.
    E. Borek, B. S. Baliga, C. W. Gehrke, K. C. Kuo, S. Belman, W. Troll and T. P. Waalkes, High turnover rate of transfer RNA in tumor tissue, Cancer Res. 37: 3362 (1977).Google Scholar
  6. 6.
    J. Speer, C. W. Gehrke, K. C. Kuo, T. P. Waalkes and E. Borek, tRNA breakdown products as markers for cancer, Cancer 44: 2120 (1979).CrossRefGoogle Scholar
  7. 7.
    C. W. Gehrke, K. C. Kuo, T. P. Waalkes and E. Borek, Patterns of urinary excretion of modified nucleosides, Cancer Res. 39: 1150 (1979).Google Scholar
  8. 8.
    R. W. Trewyn, R. Glaser, D. R. Kelly, D. G. Jackson, W. P. Graham and C. E. Speicher, Elevated nucleoside excretion by patients with nasopharyngeal carcinoma: Preliminary diagnostic/prognostic evaluations, Cancer (in press).Google Scholar
  9. 9.
    R. W. Trewyn and S. J. Kerr, Altered growth properties of Chinese hamster cells exposed to 1-methylguanine and 7-methylguanine, Cancer Res. 38: 2285 (1978).Google Scholar
  10. 10.
    R. W. Trewyn, J. M. Lehman and S. J. Kerr, Cell transformation by exogenous methylated purines, Adv. Enz. Reg. 16: 335 (1978).CrossRefGoogle Scholar
  11. 11.
    Y. Kuchino and E. Borek, Changes in transfer RNA’s in human malignant trophoblastic cells (BeWo line), Cancer Res. 36: 2932 (1976).Google Scholar
  12. 12.
    J. T. Muchinski and M. Marini, Tumor-associated phenylalanyl transfer RNA found in a wide spectrum of rat and mouse tumors but absent in normal adult, fetal, and regenerating tissues, Cancer Res. 39: 1253 (1979).Google Scholar
  13. 13.
    J. R. Katze, Alterations in SVT2 cell transfer RNA’s in response to cell density and serum type, Biochim. Biophys. Acta 383: 131 (1975).CrossRefGoogle Scholar
  14. 14.
    N. Okada, N. Shindo-Okada, S. Sato, Y. H. Itoh, K. Oda and S. Nishimura, Detection of unique tRNA species in tumor tissues by Escherichia coli guanine insertion enzyme, Proc. Natl. Acad. Sci. USA 75: 4247 (1978).CrossRefGoogle Scholar
  15. 15.
    C. W. Gehrke, K. C. Kuo, G. E. Davis, R. D. Suits, T. P. Waalkes and E. Borek. Quantitative high performance liquid chromatography of nucleosides in biological materials, J. Chromatog. 150: 455 (1978).CrossRefGoogle Scholar
  16. 16.
    J. M. Lehman and V. Defendi, Changes in deoxyribonucleic acid synthesis regulation in Chinese hamster cells infected with Simian virus 40, J. Virol. 6: 738 (1970).Google Scholar
  17. 17.
    R. Wilkinson and S. J. Kerr, Alteration in tRNA methyl-transferase activity in mengovirus infection: Host range specificity. J. Virol. 12: 1013 (1973).Google Scholar
  18. 18.
    N. Okada and S. Nishimura, Isolation and characterization of a guanine insertion enzyme, a specific tRNA transglycosylase, from Escherichia coli, Biol. Chem. 254: 3061 (1979).Google Scholar
  19. 19.
    N. K. Howes and W. R. Farkas, Studies with a homogeneous enzyme from rabbit erythrocytes catalyzing the insertion of guanine into tRNA, J. Biol. Chem. 253: 9082 (1978).Google Scholar
  20. 20.
    R. Glaser, M. Nonoyama, R. T. Szymanowski and W. Graham, Human nasopharyngeal carcinomas positive for Epstein-Barr virus DNA in North America, J. Natl. Cancer Inst. 64: 1317 (1980).Google Scholar
  21. 21.
    R. W. Trewyn, S. J. Kerr and J. M. Lehman, Karyotype and tumorigenicity of 1-methylguanine-transformed Chinese hamster cells, J, Natl, Cancer Inst. 62: 633 (1979).Google Scholar
  22. 22.
    Y. C. Cheng, J. Y. Chen, R. Glaser and W. Henle, Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma, Proc. Natl. Acad. Sci. USA 77: 6162 (1980).CrossRefGoogle Scholar
  23. 23.
    K. H. Ibsen and W. H. Fishman, Developmental gene expression in cancer, Biochim. Biophys. Acta 560: 243 (1979).Google Scholar
  24. 24.
    J. R. Katze and W. T. Beck, Administration of queuine to mice relieves modified nucleoside queuosine deficiency in Ehrlich ascites tumor tRNA, Biochem. Biophys. Res. Commun. 96: 313 (1980).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • Ronald W. Trewyn
    • 1
    • 2
    • 3
  • Mark S. Elliott
    • 1
    • 2
    • 3
  • Ronald Glaser
    • 1
    • 2
    • 3
  • Michael R. Grever
    • 1
    • 2
    • 3
  1. 1.Department of Physiological Chemistry (R.W.T., M.S.E.)The Ohio State UniversityColumbusUSA
  2. 2.Department of Medical Microbiology & Immunology (R.G.)The Ohio State UniversityColumbusUSA
  3. 3.Department of Medicine (M.R.G.)The Ohio State UniversityColumbusUSA

Personalised recommendations